NEWBORN CALF SERUM MARKET ANALYSIS

Newborn Calf Serum Market, By Origin (New Zealand Origin, U.S. Origin, Australia Origin, and Others (Brazil Origin, Mexico Origin, etc.)), By Application (Drug Discovery, Cell Media Culture, and Others), By End User (Biotechnology & Pharmaceutical Industries, Academic Institutes, and Others (Research labs and Diagnostic Labs, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Nov 2022
Code : CMI5331
Pages :420
Formats :
Excel and PDF
Industry : Biotechnology

Leading Companies

Key players are involved in expanding their services for cell therapy, which is expected to drive the growth of the global newborn calf serum market over the forecast period.

Newborn calf serum is a key ingredient in cell culture. Market players are investing in large scale in cell culture research. Companies are expanding their services toward cell therapy, therefore, these factors are expected to increase the use of newborn calf serum in future which will boost the growth of global newborn calf serum market. For instance, in June 2022, NorthX Biologics, a biologics company with the help of Alder Therapeutics, a pharmaceutical company expanded its services for cell therapy and established Good Manufacturing Practice (GMP)-manufacturing labs at Matfors facility and Karolinska University Hospital campus in Stockholm. NorthX is doing this expansion due to increasing needs of patients and growing cell therapies market.

Global Newborn Calf Serum Market – Competitive Landscape

Major players operating in the global newborn calf serum market include HiMedia Laboratories, Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Corning Inc., Atlas Biologicals, Inc., TCS Biosciences Ltd., Bovogen Biologicals Pty Ltd., Novus Biologicals, LLC, Capricorn Scientific, PAN-Biotech GmbH, Atlanta Biologicals, Inc., Rockey Mountain Biologicals, GE Healthcare, Serana, and Zhejiang Tianhang Biotechnology.